Streetbeat News

Corporate News

VVX

V2X Inc. has been awarded a significant $921 million Bridge to Enduring Synthetic Training Environment Tactical Engagement Simulation Systems (BEST MAC) contract by the U.S. Army. The ten-year contract will support the Army's training simulation devices, helping modify and extend their product life to meet evolving military requirements.

Portfolio Pulse from

March 26, 2025 | 12:15 pm

LVO

LiveOne (LVO) announced reaching 1.4 million subscribers and ad-supported users, driven by its partnership with Tesla. The company's advertising pilot program has attracted top brands, signaling growing platform engagement and potential revenue expansion.

Portfolio Pulse from

March 26, 2025 | 12:15 pm

MBX

MBX Biosciences, a clinical-stage biopharmaceutical company, will present at the 24th Annual Needham Virtual Healthcare Conference on April 7, 2025. CEO Kent Hawryluk will deliver a podium presentation and participate in one-on-one meetings, with a live webcast available on the company's website.

Portfolio Pulse from

March 26, 2025 | 12:15 pm

ABSI

Absci Corporation, a generative AI drug creation company, has announced its upcoming participation in investor conferences. This indicates the company is actively engaging with potential investors and seeking to communicate its strategic vision and progress.

Portfolio Pulse from

March 26, 2025 | 12:15 pm

CIVI

Pomerantz Law Firm is investigating potential securities fraud at Civitas Resources (CIVI) following the company's Q4 2024 financial results. The company missed consensus estimates, announced a 10% workforce reduction, and terminated two key executives. The stock price dropped 18.15% after these announcements.

Portfolio Pulse from

March 26, 2025 | 12:15 pm

BGC

BGC Group, a financial services company listed on Nasdaq, has reaffirmed its previously stated outlook ranges for revenue and pre-tax Adjusted Earnings for the first quarter of 2025. This update suggests the company expects consistent financial performance without significant changes to its earlier projections.

Portfolio Pulse from

March 26, 2025 | 12:15 pm

HUMA

Humacyte, a clinical-stage biotechnology company, will release its fourth quarter and full year 2024 financial results on March 28, 2025. The company recently received FDA Biologics License Application approval for its acellular tissue engineered vessel (ATEV) in extremity vascular trauma and continues to advance clinical trials in various vascular applications.

Portfolio Pulse from

March 26, 2025 | 12:15 pm

TRMB

Trimble Inc. (TRMB) received a Nasdaq notification on March 20, 2025, indicating non-compliance with listing rules due to a delayed Form 10-K filing for fiscal year 2024. The company has 60 days to submit a compliance plan and potentially receive a 180-day extension until July 2, 2025. The delay stems from previous financial reporting amendments, but Trimble does not expect significant changes to its previously announced financial results.

Portfolio Pulse from

March 26, 2025 | 12:15 pm

TOYO

TOYO Co., Ltd announced plans to expand its solar cell manufacturing facility in Ethiopia, increasing production capacity from 2GW to 4GW. The $47 million expansion is scheduled to begin in April 2025 and be completed by July 2025, with production starting in August 2025. This move is driven by strong global demand for high-performance solar cells.

Portfolio Pulse from

March 26, 2025 | 12:15 pm

ALGS

Aligos Therapeutics presented positive Phase 1 and Phase 2a clinical trial results for two drug candidates: ALG-000184 for hepatitis B virus (HBV) and ALG-055009 for metabolic dysfunction-associated steatohepatitis (MASH). The data demonstrated significant viral suppression in HBV patients and substantial liver fat reduction in MASH patients.

Portfolio Pulse from

March 26, 2025 | 12:15 pm